Cardiovascular Biomarkers
Cross-source consensus on Cardiovascular Biomarkers from 1 sources and 7 claims.
1 sources · 7 claims
Uses
How it works
Comparisons
Evidence quality
Highlighted claims
- Standard lipid panels do not capture immune, oxidative, and particle-level dimensions of cardiovascular risk. — Functional Medicine Approach to Cardiovascular Biomarkers
- A functional medicine cardiovascular evaluation extends testing to markers reflecting inflammation, oxidative stress, and particle burden. — Functional Medicine Approach to Cardiovascular Biomarkers
- ApoB provides a direct count of atherogenic lipoprotein particles because each particle has one ApoB molecule. — Functional Medicine Approach to Cardiovascular Biomarkers
- LDL particle number is described as more predictive of risk than LDL-C alone. — Functional Medicine Approach to Cardiovascular Biomarkers
- High-sensitivity CRP reflects cardiovascular-specific systemic inflammation. — Functional Medicine Approach to Cardiovascular Biomarkers
- Lp-PLA2 reflects active plaque formation and increasing atherogenic burden. — Functional Medicine Approach to Cardiovascular Biomarkers
- Myeloperoxidase reflects oxidative stress burden, active inflammation, and endothelial injury in the vessel wall. — Functional Medicine Approach to Cardiovascular Biomarkers